Drugs / Pituitrin
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05727618 | May 2026 → Dec 2028 | pulmonary hypertension | Qianfoshan Hospital | Suspended | No outcome recorded |
| — | NCT03106831 | Oct 2017 → Dec 2018 | arterial disorder | Beijing Anzhen Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pituitrin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03106831 ↗ |
| Route | Intravenous | “injected by intravenous pump” NCT05727618 ↗ |